Lakefront Biotherapeutics NV (LKFT) revenue

Revenue · fiscal 2025
€1.11B

Lakefront Biotherapeutics NV (LKFT) reported revenue of €1.11B in fiscal 2025 (the year ended December 31, 2025). That is 303.5% higher than the €275.65M of fiscal 2024. Figures as of 18 Nov 2026, 11:34 UTC, from Yahoo Finance.

Key facts

Revenue, fiscal 2025
€1.11B
Change on fiscal 2024
+303.5%
Highest on record
€1.11Bfiscal 2025
Lowest on record
€239.72Mfiscal 2023
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in EUR. Figures, not advice.

Lakefront Biotherapeutics NV revenue, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was €1.11B in fiscal 2025 and the lowest €239.72M in fiscal 2023.

History · 4 fiscal years

Revenue by fiscal year

Lakefront Biotherapeutics NV revenue, year by year

Lakefront Biotherapeutics NV (LKFT) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025€1.11B 303.5% up
2024€275.65M 15.0% up
2023€239.72M 0.6% down
2022€241.25M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on LKFT

Lakefront Biotherapeutics NV, figure by figure

Lakefront Biotherapeutics NV (LKFT) overview: price, valuation and scorecard

Lakefront Biotherapeutics NV revenue: questions and answers

What is Lakefront Biotherapeutics NV's revenue?

Lakefront Biotherapeutics NV (LKFT) reported revenue of €1.11B in fiscal 2025 (the year ended December 31, 2025). That is 303.5% higher than the €275.65M of fiscal 2024.

What are the highest and lowest revenue figures on record for Lakefront Biotherapeutics NV?

Across the 4 fiscal years on record (2022–2025), the highest was €1.11B in fiscal 2025 and the lowest €239.72M in fiscal 2023.

How is Lakefront Biotherapeutics NV's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Lakefront Biotherapeutics NV it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Lakefront Biotherapeutics NV (LKFT) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/LKFT/revenue

Underlying data: Yahoo Finance.